People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other Health Care, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Greenbrook TMS Inc. | — | Other Health Care | Series B | $50.6M | $187.1M | 2021 |
| Qlaris Bio, Inc. | — | Biotechnology | Series B | $37.8M | $22.4M | 2024 |
| TearLab Corp | — | Other Health Care | Series A | $23.5M | $35.3M | 2009 |
| Envisia Therapeutics, Inc. | — | Biotechnology | Series A | $14.7M | $365.8M | 2015 |
| Encore Vision, Inc. | — | Other | Series A | $9.8M | $68.1M | 2014 |
| TherOptix, Inc. | — | Other | Series A | $5.5M | $83.2M | 2019 |
Adrienne Graves at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Adrienne Graves on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Lindstrom | 3 | 13 |
| Elias Vamvakas | 2 | 3 |
| Wende Hutton | 1 | 16 |
| Stephen Bloch | 1 | 15 |
| Ed Mathers | 1 | 11 |
| Adele Oliva | 1 | 9 |
| Richard L Lindstrom | 1 | 8 |
| Tyler Stowater | 1 | 7 |
| Robert Higgins | 1 | 7 |
| Paul Karpecki | 1 | 6 |
| Adele C. Oliva | 1 | 5 |
| Seth Rudnick | 1 | 5 |
| William Leonard | 1 | 5 |
| Michael Aceti | 1 | 4 |
| Neal Fowler | 1 | 4 |
| Eric Linsley | 1 | 4 |
| Garrett Vygantas | 1 | 4 |
| Gary Phillips | 1 | 4 |
| Ronald M. Hunt | 1 | 4 |
| Ron Hunt | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.